298 related articles for article (PubMed ID: 8080389)
21. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease.
Levine AJ; Battista M
Arch Clin Neuropsychol; 2004 Sep; 19(6):769-78. PubMed ID: 15288330
[TBL] [Abstract][Full Text] [Related]
22. The epidemiology of estrogen replacement therapy and Alzheimer's disease.
Henderson VW
Neurology; 1997 May; 48(5 Suppl 7):S27-35. PubMed ID: 9153164
[TBL] [Abstract][Full Text] [Related]
23. Estrogen deficiency and risk of Alzheimer's disease in women.
Paganini-Hill A; Henderson VW
Am J Epidemiol; 1994 Aug; 140(3):256-61. PubMed ID: 8030628
[TBL] [Abstract][Full Text] [Related]
24. Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment.
Mulnard RA; Corrada MM; Kawas CH
Curr Neurol Neurosci Rep; 2004 Sep; 4(5):368-73. PubMed ID: 15324602
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging.
Kawas C; Resnick S; Morrison A; Brookmeyer R; Corrada M; Zonderman A; Bacal C; Lingle DD; Metter E
Neurology; 1997 Jun; 48(6):1517-21. PubMed ID: 9191758
[TBL] [Abstract][Full Text] [Related]
26. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.
Olichney JM; Galasko D; Salmon DP; Hofstetter CR; Hansen LA; Katzman R; Thal LJ
Neurology; 1998 Aug; 51(2):351-7. PubMed ID: 9710002
[TBL] [Abstract][Full Text] [Related]
27. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease.
Seshadri S; Zornberg GL; Derby LE; Myers MW; Jick H; Drachman DA
Arch Neurol; 2001 Mar; 58(3):435-40. PubMed ID: 11255447
[TBL] [Abstract][Full Text] [Related]
28. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.
Grady D; Yaffe K; Kristof M; Lin F; Richards C; Barrett-Connor E
Am J Med; 2002 Nov; 113(7):543-8. PubMed ID: 12459399
[TBL] [Abstract][Full Text] [Related]
29. Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women.
Steffens DC; Norton MC; Plassman BL; Tschanz JT; Wyse BW; Welsh-Bohmer KA; Anthony JC; Breitner JC
J Am Geriatr Soc; 1999 Oct; 47(10):1171-5. PubMed ID: 10522948
[TBL] [Abstract][Full Text] [Related]
30. Estrogen replacement therapy in older women: a neuropsychological and brain MRI study.
Schmidt R; Fazekas F; Reinhart B; Kapeller P; Fazekas G; Offenbacher H; Eber B; Schumacher M; Freidl W
J Am Geriatr Soc; 1996 Nov; 44(11):1307-13. PubMed ID: 8909345
[TBL] [Abstract][Full Text] [Related]
31. Estrogen replacement therapy in the elderly.
Paganini-Hill A
Zentralbl Gynakol; 1996; 118(5):255-61. PubMed ID: 8701621
[TBL] [Abstract][Full Text] [Related]
32. Estrogen replacement therapy and cognitive decline in older community women.
Matthews K; Cauley J; Yaffe K; Zmuda JM
J Am Geriatr Soc; 1999 May; 47(5):518-23. PubMed ID: 10323642
[TBL] [Abstract][Full Text] [Related]
33. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
[TBL] [Abstract][Full Text] [Related]
34. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
[TBL] [Abstract][Full Text] [Related]
35. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
36. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
37. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease.
Stern Y; Richards M; Sano M; Mayeux R
Arch Neurol; 1993 Oct; 50(10):1040-5. PubMed ID: 8215961
[TBL] [Abstract][Full Text] [Related]
38. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports.
Ohkura T; Isse K; Akazawa K; Hamamoto M; Yaoi Y; Hagino N
Dementia; 1995; 6(2):99-107. PubMed ID: 7606287
[TBL] [Abstract][Full Text] [Related]
39. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
40. Can estrogen play a significant role in the prevention of Alzheimer's disease?
Kesslak JP
J Neural Transm Suppl; 2002; (62):227-39. PubMed ID: 12456066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
